As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S.

Sadly, the number of young people dying through drug overdoses is also increasing in B.C., with drug poisoning being the ...

The hemp market in 2026 looks very different from just a few years ago. Clearer rules, better lab testing, and stronger buyer awareness have changed how hemp products are evaluated and discussed. One ...

Among the list of items approved by the Kosciusko County Council Thursday, Jan. 8, were the salary ordinance amendment for ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

As 2026 kicks off, so does our search for the next class of the Forbes Under 30 Europe list. Plus, news from the Under 30 ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering ...

On 8 January 2026, Organon announced an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) across France, Denmark, Iceland, Sweden, Finland and Norway for patients with ...

PRESS RELEASE Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes ...

Agreement expands Madrigal's pipeline and strengthens its leadership in pioneering MASH therapiesDGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra- (resmetirom) for poten ...

Korean films and television series have surged to the top of global streaming rankings at the start of the year, reinforcing ...